Training-Aortic Dissection: Update on Imaging and Treatment-TW
Please join us for a complimentary educational dinner, hosted by the University of Chicago Medicine. Our experts in cardiac and vascular surgery will speak on a range of current and controversial issues related to aortic disease. This CME event is designed for emergency medicine physicians, cardiologists, and primary care physicians. Midlevel providers are also welcome to join us.
Target Audience
The symposium has been designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the prevention, management, and elimination of lymphoma.
Learning Objectives
After attending this educational activity, participants will be able to:
- Understand immunotherapy and CAR-T cells in lymphoma
- Describe the importance of PD-1 signaling in lymphoma
- Identify new molecular and genetic targets in DLBCL
- Treat frontline follicular lymphoma with biologic agents versus chemotherapy
- Understand the state of the art treatment for HL and describe the late toxicities associated with treatment
- Discuss the role of stem cell transplant in mantle cell lymphoma
- 9.25 AMA PRA Category 1 Credit™
- 9.25 Participation
HOTEL ACCOMMODATIONS
W Chicago City Center
172 West Adams Street
Chicago, IL 60603
312-332-1200
Set in the middle of the famed Chicago Loop, W Chicago City Center is close to the Willis Tower (formerly the Sears Tower), the Art Institute of Chicago, music at Millennium Park, and the theater district. The W is a world-class venue, and Chicago is a world-class city. After the conference adjourns each day you can enjoy premium shopping, beautiful architecture, famous art, and award-winning theater just a short walk away. Step out – the Windy City surrounds you.
RESERVATIONS AND RATES
To reserve a room at this special rate, please call the hotel at 312-917-5782 and identify yourself as part of the University of Chicago International Ultmann Chicago Lymphoma Symposium 2015 or book online here.
Room Rates:
Single Room: $189 | Double Room: $209
Check-in: 3:00pm, Check-out: 12:00pm
Rates do not include applicable state and local taxes.
Individual guests must make their own reservations by 5:00 pm Friday, April 10, 2015. After the cut-off date, it is at the hotel’s discretion whether to accept additional reservations, which will be subject to prevailing group rates based on availability. An early departure charge equal to one (1) night plus tax will apply for check out prior to the confirmed checkout date. Guests wishing to avoid this fee must advise the hotel at or before check-in.
Individual reservations can be canceled 24 hours or more prior to arrival without penalty. If a reservation is canceled within 24 hours of arrival, a one (1) night room and tax charge will apply.
Parking: The daily parking fee at the W Chicago City Center is $25 for local registered attendees driving to the conference.
Jeremy S. Abramson, MD, MMSc
Director, Lymphoma Program
Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine
Harvard Medical School
Boston, MA
Nancy L. Bartlett, MD
Professor of Medicine
Koman Chair in Medical Oncology
Washington University School of Medicine
St. Louis, MO
Catherine M. Bollard, MD
Professor of Pediatrics and Microbiology, Immunology, Tropical Medicine
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children’s National Health System
The George Washington University
Washington, DC
Timothy S. Fenske, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Milwaukee, WI
Richard R. Furman, MD
Morton Coleman, MD Distinguished Associate Professor of Medicine
Director, CLL Research Center
Weill Cornell Medical College
New York, NY
Mary Gospodarowicz, MD, FRCPC, FRCR (Hon)
Medical Director, Princess Margaret Hospital/University Health Network
Professor, Department of Radiation Oncology
University of Toronto
Regional Vice President, Cancer Care Ontario
Ontario, Canada
Michael Hallek, MD
Director
Department I of Internal Medicine
Center of Integrated Oncology Köln-Boon
University of Cologne
Cologne, Germany
Reem Karmali, MD
Assistant Professor of Medicine
Division of Hematology, Oncology, and Cell Therapy
Rush University Medical Center/Rush University
Chicago, IL
Justin Kline, MD
Assistant Professor of Medicine
The University of Chicago
Chicago, IL
Chadi Nabhan, MD, FACP
Associate Professor of Medicine
Medical Director, Clinical Cancer Center and Cancer Clinics
The University of Chicago
Chicago, IL
Owen O’Connor, MD, PhD
Professor of Medicine and Experimental Therapeutics
Director of the Center for Lymphoid Malignancies
Columbia University Medical Center
New York Presbyterian Hospital
New York, NY
Adam Petrich, MD
Assistant Professor of Medicine and Hematology and Oncology
Northwestern University Feinberg School of Medicine
Chicago, IL
Margaret A. Shipp, MD
Chief, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA
Mitchell Smith, MD, PhD
Director, Lymphoid Malignancy Program
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH
Eduardo Sotomayor, MD
Susan and John Sykes Endowed Chair in Hematologic Malignancies
Scientific Director, DeBartolo Family Personalized Medicine Institute
Professor of Oncological Sciences, Pathology, and Cell Biology
University of South Florida College of Medicine
Tampa, FL
Patrick Stiff, MD
Coleman Professor of Oncology
Director, Cancer Center
FCO Division Director, Hematology/Oncology
Medical Director, Cancer Center
Chicago, IL
Faculty Disclosure
It is the policy of The University of Chicago to ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational activities. Individuals who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Full disclosure of this information will be published in the activity materials.